香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因依 賴該等內容而引致之任何損失承擔任何責任。 2025年公司債券（第一期）（品種一）公開發行（續發行）完畢 茲提述中國銀河證券股份有限公司（「本公司」）日期為2025年1月23日的通函以 及2025年2月17日之公告。於2025年2月17日召開的2025年第一次臨時股東大會 上，本公司通過了股東大會對本公司董事會（「董事會」）的授權方案的修訂，據 此，股東大會授權董事會發行債務融資工具，發行規模合計不超過本公司最近一 期經審計淨資產的350%。 亦提述本公司(i)日期為2024年9月2日之公告，內容有關本公司收到中國證券監 督管理委員會的批覆，核准本公司向專業投資者公開發行面值總額不超過人民幣 200億元的公司債券；以及(ii)日期為2025年8月7日之公告，內容有關本公司已於 2025年8月7日完成向專業投資者公開發行2025年公司債券（第一期）。 董事會欣然宣佈，根據上述股東授權及中國證券監督管理委員會的批覆，本公司 已於2025年9月1日完成 ...

证券代码：601881 证券简称：中国银河 公告编号：2025-070 中国银河证券股份有限公司2024年面向专业投资者 公开发行公司债券（第一期）（品种二）（续发行） 发行结果公告 本期续发行债券存在承销机构及其关联方认购情况，为主承销商国信证券 股份有限公司参与认购并获配本期续发行债券面值人民币 0.5 亿元，其关联方 南方基金管理股份有限公司参与认购并获配本期续发行债券面值人民币 0.9 亿 元，其关联方华润深国投信托有限公司参与认购并获配本期续发行债券面值人 民币 0.5 亿元。前述认购报价及程序均符合相关法律法规的规定。 2025 年 9 月 2 日 特此公告。 中国银河证券股份有限公司董事会 | 本公司及董事会全体成员保证公告内容的真实、准确和完整，对公告 | | --- | | 的虚假记载、误导性陈述或者重大遗漏负连带责任。 | 中国银河证券股份有限公司（以下简称"发行人"）面向专业投资者公开 发行面值不超过 200 亿元（含 200 亿元）的公司债券已经上海证券交易所审核 同意并经中国证券监督管理委员会"证监许可〔2024〕1197 号文"注册。 根据《中国银河证券股份有限公司 2024 年面 ...

证券代码：601881 证券简称：中国银河 公告编号：2025-071 | 本公司及董事会全体成员保证公告内容的真实、准确和完整，对公告 | | --- | | 的虚假记载、误导性陈述或者重大遗漏负连带责任。 | 中国银河证券股份有限公司（以下简称"发行人"）面向专业投资者公开 发行面值不超过 200 亿元（含 200 亿元）的公司债券已经上海证券交易所审核 同意并经中国证券监督管理委员会"证监许可〔2024〕1197 号文"注册。 根据《中国银河证券股份有限公司 2025 年面向专业投资者公开发行公司 债券（第一期）（品种一）（续发行）募集说明书》，中国银河证券股份有限 公司 2025 年面向专业投资者公开发行公司债券（第一期）（品种一）（续发 行）（以下简称"本期续发行债券"）的发行面值总额不超过人民币 30 亿元 （含 30 亿元）。本期续发行债券期限为 3 年（起息日为 2025 年 8 月 7 日， 本金兑付日期为 2028 年 8 月 7 日），票面利率为 1.79%。 中国银河证券股份有限公司2025年面向专业投资者 公开发行公司债券（第一期）（品种一）（续发行） 发行结果公告 中国银河证券股份 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年8月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 中國銀河證券股份有限公司 呈交日期: 2025年9月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 H | | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 06881 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 3,690,984,633 | RMB | | 1 | RMB | | 3,690,984,633 | | 增加 / 減少 (-) | | | 0 | | | | RMB | | 0 | | 本月底結存 | | | 3,690,984,633 | RMB | | 1 | RMB | | 3,690,984,633 | | 2. 股 ...

Group 1 - The core viewpoint of the report is a cautious recommendation for Baoxiniang (002154.SZ) with a latest price of 3.8 yuan [1] - Baoxiniang and Baoniao brand revenues are experiencing fluctuations, while Haji Si maintains steady growth [1] - Overall gross margin has slightly increased, but rising expenses are dragging down net profit [1]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年8月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 中國銀河證券股份有限公司 呈交日期: 2025年9月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 H | | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 06881 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 3,690,984,633 | RMB | | 1 | RMB | | 3,690,984,633 | | 增加 / 減少 (-) | | | 0 | | | | RMB | | 0 | | 本月底結存 | | | 3,690,984,633 | RMB | | 1 | RMB | | 3,690,984,633 | | 2. 股 ...

Group 1 - The core viewpoint of the report is that China Galaxy has given a "recommended" rating for Liugong (000528.SZ) based on several positive indicators [1] - Domestic sales are recovering, and overseas sales and profitability have reached new highs during the same period [1] - The market share of excavators has increased both domestically and internationally, with a significant growth in global sales of electrical equipment and accelerated growth in emerging businesses [1] Group 2 - The gross profit margin has improved year-on-year, although there has been a slight increase in the expense ratio [1] - There has been an increase in accounts receivable exposure, which has impacted operating cash flow due to the company's own financing leasing business [1]

Core Viewpoint - Beijing Junzheng's performance in the first half of 2025 met expectations, with revenue and net profit showing steady growth compared to the previous year [2][4]. Financial Performance - In the first half of 2025, the company achieved operating revenue of 2.249 billion yuan, a year-on-year increase of 6.75%, and a total profit of 228 million yuan, up 3.39% year-on-year [2]. - The net profit attributable to shareholders reached 203 million yuan, reflecting a 2.85% increase year-on-year [2]. - For Q2 2025, the company reported operating revenue of 1.189 billion yuan, an 8.10% year-on-year increase, and a net profit of 129 million yuan, which is a 17.22% increase year-on-year [2]. Revenue Breakdown - Revenue from storage chips was 1.384 billion yuan, a 5.20% increase year-on-year, accounting for 61.56% of total revenue [2]. - Revenue from analog and interconnect chips was 244 million yuan, up 5.02% year-on-year, representing 10.84% of total revenue [2]. - Other businesses generated revenue of 1.189 million yuan, a significant increase of 2543.51% year-on-year, contributing 0.53% to total revenue [2]. - Revenue from computing chips was 604 million yuan, reflecting a 15.59% year-on-year growth [2]. Profitability and Cost Management - The overall gross margin for the first half of 2025 was 35.54%, a decrease of 2.03 percentage points year-on-year [3]. - The gross margin for Q2 2025 was 34.76%, down 2.91 percentage points year-on-year and 1.64 percentage points quarter-on-quarter [3]. - The gross margin for storage chips was 33.48%, down 1.87 percentage points year-on-year, while analog and interconnect chips had a gross margin of 51.14%, down 0.95 percentage points [3]. - The company maintained a total expense ratio of 25.26%, a decrease of 1.10 percentage points year-on-year, indicating effective cost control [3]. Strategic Focus - The company is focused on the AI storage and computing chip sectors, with a product strategy centered on "computing + storage + analog" [4]. - The main products in the storage chip segment include high-density, high-performance SRAM, DRAM, and Flash, targeting automotive, industrial, and medical markets [4]. - The analog and interconnect chip product line includes various LED drivers and DC/DC converters, catering to automotive, industrial, and consumer electronics sectors [4]. Investment Outlook - Revenue projections for 2025-2027 are estimated at 5.012 billion yuan, 5.968 billion yuan, and 7.032 billion yuan, respectively [4]. - Net profit forecasts for the same period are 549 million yuan, 628 million yuan, and 779 million yuan, with corresponding price-to-earnings ratios of 66.0x, 57.75x, and 46.57x [4].

Core Viewpoint - The report indicates that Tiankang Biological (002100) has shown steady revenue growth and improved profitability in H1 2025, with a buy rating recommended by China Galaxy Securities [1][2]. Financial Performance - In H1 2025, the company's revenue reached 8.847 billion yuan, a year-on-year increase of 10.68%, with net profit attributable to shareholders at 338 million yuan, up 22.27% year-on-year [2]. - For Q2 2025, revenue was 4.666 billion yuan, also reflecting a 10.68% year-on-year growth, but net profit decreased by 14.59% to 190 million yuan [2]. - The comprehensive gross margin for H1 2025 was 12.07%, an increase of 0.58 percentage points year-on-year, while the expense ratio decreased to 7.15% [2]. Business Segments - The revenue contributions from various segments in H1 2025 included pig farming (2.849 billion yuan, -0.95% YoY), feed (2.434 billion yuan, -14.24% YoY), agricultural product processing (1.449 billion yuan, +97.6% YoY), veterinary biological products (482 million yuan, -3.67% YoY), and corn silage (1.305 billion yuan, +72.32% YoY) [2][3]. - The company aims to achieve a pig output target of 3.5 to 4 million heads in 2025, representing a year-on-year increase of 15.57% to 32.08% [3]. Research and Development - In H1 2025, the company invested 113 million yuan in R&D, a decrease of 26.85% year-on-year, with new products expected to drive future growth in the vaccine business [4]. - The targets for animal vaccines and feed sales in 2025 are set at 2.4 billion milliliters and 2.9 million tons, respectively, indicating growth of 16.28% and 2.9% year-on-year [4]. Investment Outlook - The company is positioned as an integrated farming enterprise with stable growth in feed and veterinary medicine businesses, alongside a positive outlook for pig farming due to ongoing cost optimization [4]. - EPS forecasts for 2025 and 2026 are 0.54 yuan and 0.68 yuan, respectively, with corresponding PE ratios of 12 times and 10 times [4].

智通财经APP获悉，中国银河证券发布研报称，8月通信行业涨幅居全行业首位，此轮上涨主要动因在 于业绩驱动。在估值不确定性和业绩确定性的AI+大发展趋势下，通信AI景气度仍处上升通道，估值仍 然低位区域。政策支持力度加大，科技引领，新质生产力筑基，高成长性增强。算力数据中心存在大型 化、高速互连化的趋势，而通信行业作为信号传输的关键环节，受益于大型智算中心的增长、数据互联 速率不断提升的驱动以及应用场景的进一步开拓，市场空间有望进一步打开，展望未来，通信行业有望 走出长牛态势。 中国银河证券主要观点如下： 业绩超预期，通信AI景气度仍处上升通道，估值仍然低位区域。 此轮上涨主要动因在于业绩驱动，通信行业相关公司业绩超预期的同时也逐步向上下游相关企业赋能。 通信行业相关公司较早布局，且同人工智能基础设施的契合度较高，在全球人工智能行业下游企业资本 开支不断超预期的基础上，凭借目身优质的工业化能力以及产品的多样性，其全球市场份额止在持续提 升，在行业高景气β中自身的α也持续上行。若以2025年业绩为锚，相关企业虽然估值中枢有所提升， 但若以Wnd一致预期业绩作为标准，明年仍处于相对低估态势，未来整体估值区间处于20 ...